Cellectis (CLLS) Interest Coverage Ratio (2021 - 2026)
Cellectis (CLLS) recorded quarterly Interest Coverage Ratio of 5.66 in Q1 2026, up 3060.88% quarter-over-quarter from 0.19 in Q4 2025, and up 309.23% on a YoY basis from 1.38 in Q1 2025.
Cellectis (CLLS) Interest Coverage Ratio (2021 - 2026) Analysis & Trends
Cellectis' Interest Coverage Ratio history runs 6 years deep, the most recent figure standing at 5.66 for Q1 2026.
- In Q1 2026, Interest Coverage Ratio rose 309.23% year-over-year to 5.66; the TTM figure through Mar 2026 stood at 0.79 (up 94.96% YoY), while the FY2025 annual figure was 1.17, up 57.67% from the prior year.
- Interest Coverage Ratio was 5.66 for Q1 2026 at Cellectis, up from 0.19 in the prior quarter.
- In the past five years, Interest Coverage Ratio ranged from a high of 25.14 in Q3 2022 to a low of 0.74 in Q3 2025.
- Historically, Interest Coverage Ratio has averaged 5.62 across 5 years, with a median of 1.38 in 2025.
- The sharpest annual moves came in 2025 and 2026: Interest Coverage Ratio tumbled 205.43% in 2025, then surged 309.23% in 2026.
- A 5-year view of Interest Coverage Ratio shows it stood at 0.26 in 2022, then tumbled by 80.04% to 0.46 in 2023, then jumped by 49.61% to 0.23 in 2024, then gained by 18.22% to 0.19 in 2025, then jumped by 3060.88% to 5.66 in 2026.
- The last three Interest Coverage Ratio figures came in at 5.66 (Q1 2026), 0.19 (Q4 2025), and 0.74 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 3.58 |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 11.50 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -258.33 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 547.67 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 11.79 |
| 10 | Cellectis | 17.40 Bn | 17.21 Bn | - | 5.66 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.66 |
| Dec 31, 2025 | -0.19 |
| Sep 30, 2025 | -0.74 |
| Jun 30, 2025 | 0.49 |
| Mar 31, 2025 | 1.38 |
| Dec 31, 2024 | -0.23 |
| Sep 30, 2024 | 0.70 |
| Jun 30, 2024 | 1.03 |
| Mar 31, 2024 | 6.66 |
| Dec 31, 2023 | -0.46 |
| Sep 30, 2023 | 12.73 |
| Jun 30, 2023 | 1.45 |
| Mar 31, 2023 | 4.53 |
| Dec 31, 2022 | -0.26 |
| Sep 30, 2022 | 25.14 |
| Jun 30, 2022 | 16.15 |
| Mar 31, 2022 | 21.52 |
| Mar 31, 2021 | 19,907.00 |